Jørgensen will step down after eight years as CEO, with a successor search underway while the company reaffirms confidence in ...

Our exclusive poll captures today's top trends and perspectives—shaped by those pharma decision-makers impacted the most.

Welireg marks the first FDA-approved non-surgical treatment option for locally advanced, unresectable, or metastatic ...

Emrelis is the first FDA-approved treatment for previously treated patients with locally advanced or metastatic non-squamous non-small cell lung cancer with high c-Met protein overexpression.

Polanco, executive VP and chief commercial officer, Novartis US, and the 2025 Healthcare Businesswomen’s Association Woman of ...

Zynyz is the first and only FDA-approved first-line treatment for adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal.

The order pushes drug companies to reduce drug prices in the United States to fall in line with other countries around the ...

Weight-loss and diabetes drugs dominated pharmaceutical spending last year, according to a new report by the American Society ...

The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

Identifying the priorities that translate to strong business outcomes—and separating the top performers from the average ...

Leandro Boer, MD, PhD, VP, US general medicines, Amgen, discusses new real-world data showing that most high-risk ...

On Sunday, President Trump posted to Truth Social that he planned on implementing a most-favored-nation policy for ...